The primary objective was To guage the efficacy of the vaccine vs . placebo in lessening cocaine use. Secondary objectives provided confirming vaccine immunogenicity through IgG anti-cocaine antibody concentrations and evaluating the protection and tolerability of vaccination by way of a twenty 7 days study and at 24 7 days https://davida185khe0.wikiap.com/user